Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Norepin

Approved

STANDARD

Norepin

United Biotech Pvt. Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 33f66aa5b2c6e82f
Company: United Biotech Pvt. Limited
Type: Standard

Approval Details

Approval Id: 33f66aa5b2c6e82f
Drug Approval Philippines Name: Norepin
Product Name: Norepin
Registration Number: DRP-10472
Brand Name: Norepin
Generic Name: Norepinephrine (as bitartrate)
Dosage Form: Concentrate Solution for Infusion
Dosage Strength: 1 mg/mL
Manufacturer: United Biotech Pvt. Limited
Importer: Delex Pharma International, Inc.
Distributor: Delex Pharma International, Inc.
Issuance Date: 24 January 2025
Expiry Date: 06 December 2030
Pharmacologic Category: Adrenergic and Dopaminergic Agent
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

33f66aa5b2c6e82f

Type

Standard

Back to Philippines FDA Approvals

Norepin - Philippines FDA Drug Approval Details